[Federal Register Volume 89, Number 10 (Tuesday, January 16, 2024)]
[Notices]
[Page 2618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00676]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the 
following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended, and the Determination of the Director, Office of 
Strategic Business Initiatives, Office of the Chief Operating Officer, 
CDC, pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP)-RFA-PS-24-039 Improving the 
Quality of Life of People with HIV Aged 50 Years and Older in the 
United States, and RFA-PS-24-042 A Bridge to Adherence: Long-Acting 
Antiretroviral Therapy for People with HIV Released from Prison.
    Dates: May 1-2, 2024.
    Times: 10 a.m.-5 p.m., EDT.
    Place: Videoconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Seraphine Pitt Barnes, Ph.D., 
M.P.H, C.H.E.S., Scientific Review Officer, National Center for HIV, 
Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control 
and Prevention, 1600 Clifton Road NE, Mailstop H24-6, Atlanta, 
Georgia 30329-4027. Telephone: (770) 488-6115; Email: 
[email protected].

    The Director, Office of Strategic Business Initiatives, Office 
of the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal 
Register notices pertaining to announcements of meetings and other 
committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and 
Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-00676 Filed 1-12-24; 8:45 am]
BILLING CODE 4163-18-P